McDermott + Bull has successfully placed Helen Routh and Beverly Huss as members of the Board of Directors at Clarius Mobile Health. They will bring their vast expertise in healthcare technology and medical devices to help Clarius continue to innovate and grow. Their...
McDermott + Bull has successfully placed Scott Corning as Vice President, Americas at Rayner Surgical Group Ltd. Scott will play a pivotal role in developing and executing the company’s strategic initiatives, including driving growth and profitability across Canada,...
McDermott + Bull has successfully placed James Hopper as Senior Director, Business Development at TSTrials. Headquartered in Buenos Aires, Argentina, James will execute TSTrials’ global growth strategy, focused on leading business development, fostering existing...
The JPM Q1 2024 MedTech Licensing and Venture report highlights the first quarter of 2024 and shows promising developments in the MedTech investment landscape. There are indications of a potential recovery and growth compared to previous years. Can we be so lucky?...
McDermott + Bull has successfully placed Tom Mock as the Director of Research and Development at NVMedTech. Tom will oversee the completion of one of the company’s main intravascular products, managing its design finalization, initiating GLP animal studies, and...
Healthcare PE activity in Q1 2024 remained subdued, marking a continuation of the downturn seen in 2023. PE sponsors announced or closed an estimated 158 deals in the quarter, maintaining the sluggish pace of 2023. Despite a somewhat more optimistic narrative around...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Privacy policyOkNo
